Addus HomeCare Q2 2024 Adj. EPS $1.35 Beats $1.21 Estimate, Sales $286.922M Beat $285.007M Estimate
Portfolio Pulse from Benzinga Newsdesk
Addus HomeCare (NASDAQ:ADUS) reported Q2 2024 adjusted EPS of $1.35, beating the $1.21 estimate. Sales were $286.922M, surpassing the $285.007M estimate. EPS increased by 26.17% YoY, and sales grew by 10.36% YoY.
August 05, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Addus HomeCare reported strong Q2 2024 earnings with an EPS of $1.35, beating estimates by 11.57%. Sales also exceeded expectations, reaching $286.922M. Both EPS and sales showed significant YoY growth.
The strong earnings report, with both EPS and sales beating analyst estimates and showing significant year-over-year growth, is likely to positively impact ADUS stock in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100